Transcription of profile - PhRMA – 米国研究製薬工業協会
{{id}} {{{paragraph}}}
Example: biology
profile - PhRMA – 米国研究製薬工業協会
ProfilePHARMACEUTICAL INDUSTRYKey FactsSee inside back cover for of Sales That Went to R&D in 20097 Domestic R&DAs a percentage of domestic sales = R&DAs a percentage of total sales = and Development (R&D) Time to develop a drug = 10 to 15 years1 Development Costs Cost to develop a drug2005 = $ billion22001 = $802 million31987 = $318 million31975 = $138 million3 Cost to develop a biologic2005 = $ billion4 Sales Generic share of market202000 = 49%2009 = 74%Approvals Drugs and biologics approved in 2009 = 349 In the 27 years since the Orphan Drug Act was established, nearly 350 orphan drugs have been Only 2 of 10 marketed drugs return revenues that match or exceed R&D of Medicines Cancer.
IMPROVING OUTCOMES FOR PATIENTS Better Results: The Impact of Today’s Medicines T oday’s medicines – the results of decades of biopharmaceutical R&D – are making important contribu-
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: